Search

Constantine A Stratakis

from Rockville, MD
Age ~59
Get Report
Also known as:
Constantine Dr Stratakis, Constantine Ekaterini Stratakis, Constantine A Strataki, Stratakis Constantine, N Stratakis
Phone and address:
415 Misty Knoll Dr, Rockville, MD 20850
(301) 315-2178
Related to:
Euthymia Stratakis, 26T UEkaterini Tsilou, 59
Connected to:
Oleg Stratan, 37Allison M Stratas, 55Beth A Stratbucker, 36Leonard J Stratchko, 75Barbara C Strate, 81Jeanne M Strate, 67Marilyn C Strate, 60Mark E Strate, 64Melissa S Strate, 30Patricia Strate, 54

Constantine Stratakis Phones & Addresses

  • 415 Misty Knoll Dr, Rockville, MD 20850 (301) 315-2178
    • s
  • 10701 Hampton Mill Ter #200, Rockville, MD 20852
  • 1373 Templeton Pl, Rockville, MD 20852 (301) 315-2178 (301) 770-4864
  • North Bethesda, MD
  • Chevy Chase, MD
  • Silver Spring, MD

Education

School / High School: University of Athens / College of Medicine / School of Health Science National & Kapodistrian

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Clinical Genetics, 1996

Specialities

Pediatric Endocrinology

Professional Records

Medicine Doctors

Constantine Stratakis Photo 1

Dr. Constantine A Stratakis, Rockville MD - MD (Doctor of Medicine)

View page
Specialties:
Pediatric Endocrinology
Address:
415 Misty Knoll Dr, Rockville, MD 20850
Certifications:
Clinical Genetics, 1996
Pediatric Endocrinology, 1995
Pediatrics, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Athens / College of Medicine / School of Health Science National & Kapodistrian
Constantine Stratakis Photo 2

Constantine A Stratakis, Bethesda MD

View page
Specialties:
Pediatrics
Pediatric Endocrinology
Medical Genetics
Clinical Genetics
M.D.
Work:
Dir Nichd NIH
10 Center Dr, Bethesda, MD 20892
Education:
(1989)

Resumes

Resumes

Constantine Stratakis Photo 3

Senior Investigator

View page
Location:
North Bethesda, MD
Work:

Senior Investigator
Constantine Stratakis Photo 4

Senior Investigator

View page
Location:
North Bethesda, MD
Work:

Senior Investigator
Education:
Georgetown University School of Medicine 1993 - 1996

Business Records

Name / Title
Company / Classification
Phones & Addresses
Constantine A. Stratakis
Constantine Stratakis MD
Pediatric Endocrinologist · Genetic Medicine · Pediatrician
10 Ctr Dr, Bethesda, MD 20892
(301) 496-4686

Publications

Us Patents

Pde11A Mutations In Adrenal Disease

View page
US Patent:
7847078, Dec 7, 2010
Filed:
Jan 19, 2007
Appl. No.:
12/161866
Inventors:
Constantine A. Stratakis - Rockville MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C07H 21/04
C12N 5/00
C12N 5/02
A61K 48/00
US Classification:
536 232, 435325, 424 9321
Abstract:
The invention provides previously uncharacterized variants of PDE11A that are correlated with a newly discovered form of Cushing Syndrome that presents at a young age. The invention also provides methods useful to research, screen for, treat, or prevent diagnose the disease using the PDE11A variants, as well as other methods relating thereto.

Protein Kinase A And Carney Complex

View page
US Patent:
20030022180, Jan 30, 2003
Filed:
Aug 23, 2001
Appl. No.:
09/935916
Inventors:
Constantine Stratakis - Rockville MD, US
Lawrence Kirschner - North Potomac MD, US
Assignee:
The Government Of USA, Department Of Health And Human Services
International Classification:
C12Q001/68
C07H021/04
C12N009/12
US Classification:
435/006000, 435/194000, 536/023200
Abstract:
The present invention provides compositions and methods useful in the diagnosis and prognosis of Carney complex (CNC), as well as methods and compositions for the identification of compounds useful in the treatment and/or prevention of CNC. In addition, the present invention provides compositions and methods useful in the diagnosis and treatment of conditions associated with skin pigmentation defects, including but not limited to freckling, as well as endocrine tumors including, but not limited to adrenal and pituitary tumors. In addition, the present invention provides methods and compositions for the diagnosis and treatment of various types of cancers associated with abnormal activity of protein kinase A. In particular, the present invention provides genetic and other sequence information, as well as assay systems that will find use in these and related areas.

Treatment Of Hormonal Disorders Of Growth

View page
US Patent:
20190314459, Oct 17, 2019
Filed:
Jun 3, 2019
Appl. No.:
16/430079
Inventors:
- Bethesda MD, US
- Angleur, BE
- Liege, BE
Constantine A. Stratakis - Bethesda MD, US
Giampaolo Trivellin - Bethesda MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Servic - Bethesda MD
UNIVERSITE DE LIEGE - Angleur
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE - Liege
International Classification:
A61K 38/31
A61K 31/48
A61K 38/17
A61K 47/60
A61K 31/713
A61K 31/437
C07K 16/28
A61K 31/352
A61K 38/27
A61K 38/12
C12N 15/113
C07K 14/705
A61K 31/473
Abstract:
The present invention refers to a GPR101 inhibitor, antagonist or inverse agonist or inverse agonist for use in preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism. Further, the present invention provides a GPR101 agonist for use in preventive and/or therapeutic treatment of disorders selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion wherein to a subject GPR101 agonist is administered.

Treatment Of Hormonal Disorders Of Growth

View page
US Patent:
20170304405, Oct 26, 2017
Filed:
Nov 12, 2015
Appl. No.:
15/525928
Inventors:
- Bethesda MD, US
- Angleur, BE
- Liege, BE
Constantine A. Stratakis - Bethesda MD, US
Giampaolo Trivellin - Bethesda MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human - Bethesda MD
UNIVERSITE DE LIEGE - Angleur
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE - Liege
International Classification:
A61K 38/31
A61K 38/17
A61K 31/473
A61K 31/437
A61K 31/352
A61K 38/27
A61K 47/60
Abstract:
The present invention refers to a GPR101 inhibitor, antagonist or inverse agonist or inverse agonist for use in preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism wherein to a subject GPR101 inhibitor, antagonist or inverse agonist is administered. Further, the present invention provides a GPR101 agonist for use in preventive and/or therapeutic treatment of disorders selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion wherein to a subject GPR101 agonist is administered. The present invention also provides GHRH inhibitors, antagonists or inverse agonists and GH antagonists for use in the therapeutic treatment of X-linked acrogigantism (X-LAG syndrome). In addition, the present invention refers to a method of increasing body mass and/or body size of livestock comprising administering to livestock an effective amount of GPR101 agonist. Further, the present invention is directed to a non-human transgenic animal, comprising as expressed transgene a gene encoding GPR101 or overexpressing endogenous GPR101 gene.
Control profile
Constantine A Stratakis from Rockville, MD, age ~59 Get Report